By employing a mouse line expressing human instead of endogenous murine Plexin-B1, we demonstrate that this anti–Plexin-B1 antibody exhibits therapeutic efficacy in preclinical models of osteoporosis and MS in vivo. The gene discussed is PLXNB1; the disease is myeloid sarcoma.